2-69387029-A-G
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001244710.2(GFPT1):c.7+36T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.594 in 1,484,594 control chromosomes in the GnomAD database, including 266,085 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001244710.2 intron
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 12Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Illumina
- congenital myasthenic syndromes with glycosylation defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GFPT1 | ENST00000357308.9 | c.7+36T>C | intron_variant | Intron 1 of 19 | 5 | NM_001244710.2 | ENSP00000349860.4 |
Frequencies
GnomAD3 genomes AF: 0.659 AC: 100169AN: 151978Hom.: 34431 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.574 AC: 74642AN: 129932 AF XY: 0.577 show subpopulations
GnomAD4 exome AF: 0.587 AC: 781747AN: 1332502Hom.: 231613 Cov.: 24 AF XY: 0.587 AC XY: 387819AN XY: 660692 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.659 AC: 100262AN: 152092Hom.: 34472 Cov.: 34 AF XY: 0.655 AC XY: 48699AN XY: 74342 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
- -
Congenital myasthenic syndrome 12 Benign:2
- -
- -
not specified Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at